Randall Moreadith Sells 6,500 Shares of Serina Therapeutics (NYSEAMERICAN:SER) Stock

Serina Therapeutics, Inc. (NYSEAMERICAN:SER) insider Randall Moreadith sold 6,500 shares of the stock in a transaction that occurred on Wednesday, January 28th. The stock was sold at an average price of $3.57, for a total transaction of $23,205.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Randall Moreadith also recently made the following trade(s):

• On Thursday, January 22nd, Randall Moreadith sold 2,500 shares of Serina Therapeutics stock. The stock was sold at an average price of $2.95, for a total transaction of $7,375.00.
• On Wednesday, January 21st, Randall Moreadith sold 2,000 shares of Serina Therapeutics stock. The stock was sold at an average price of $3.00, for a total transaction of $6,000.00.

Serina Therapeutics Trading Up 30.9%

SER traded up $0.84 during trading on Thursday, reaching $3.56. 63,160,761 shares of the stock were exchanged, compared to its average volume of 3,790,159. The company has a market cap of $37.95 million, a price-to-earnings ratio of -1.90 and a beta of 1.15. Serina Therapeutics, Inc. has a twelve month low of $1.71 and a twelve month high of $7.92.

Serina Therapeutics Company Profile

Serina Therapeutics, Inc, a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252, a POZ conjugate for the treatment of Parkinson’s disease. The company also develops SER 227 for long-acting pain relief; SER 214 to treat Parkinson’s disease; and SER 228 for the treatment of epilepsy. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc was founded in 2006 and is based in Huntsville, Alabama.